Publié le : 2006-04-01
DOI : 10.1016/S1631-0691(06)00091-6

@misc{CRBIOL_2006__329_4_CO2_0,
     title = {Editorial {Board}},
     journal = {Comptes Rendus. Biologies},
     pages = {CO2},
     publisher = {Elsevier},
     volume = {329},
     number = {4},
     year = {2006},
     doi = {10.1016/S1631-0691(06)00091-6},
     language = {en},
}

TY  - JOUR
TI  - Editorial Board
JO  - Comptes Rendus. Biologies
PY  - 2006
SP  - CO2
VL  - 329
IS  - 4
PB  - Elsevier
DO  - 10.1016/S1631-0691(06)00091-6
LA  - en
ID  - CRBIOL_2006__329_4_CO2_0
ER  - 

%0 Journal Article
%T Editorial Board
%J Comptes Rendus. Biologies
%D 2006
%P CO2
%V 329
%N 4
%I Elsevier
%R 10.1016/S1631-0691(06)00091-6
%G en
%F CRBIOL_2006__329_4_CO2_0

Editorial Board. Comptes Rendus. Biologies, Usage des anticorps monoclonaux en thérapeutique, Volume 329 (2006) no. 4, p. CO2. doi : 10.1016/S1631-0691(06)00091-6. https://comptes-rendus.academie-sciences.fr/biologies/articles/10.1016/S1631-0691(06)00091-6/